Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v4-EN
Language French English
Date Updated 2019-03-05 2019-03-05
Drug Identification Number 02223260 02223260
Brand name PROCTOSEDYL SUPPOSITORIES PROCTOSEDYL SUPPOSITORIES
Common or Proper name PrPROCTOSEDYL® 0.5% Suppositories PrPROCTOSEDYL® 0.5% Suppositories
Company Name APTALIS PHARMA CANADA ULC APTALIS PHARMA CANADA ULC
Ingredients DIBUCAINE HYDROCHLORIDE HYDROCORTISONE FRAMYCETIN SULFATE ESCULIN DIBUCAINE HYDROCHLORIDE HYDROCORTISONE FRAMYCETIN SULFATE ESCULIN
Strength(s) 5MG 5MG 10MG 10MG 5MG 5MG 10MG 10MG
Dosage form(s) SUPPOSITORY SUPPOSITORY
Route of administration RECTAL RECTAL
Packaging size 12 and 24 suppositories 12 and 24 suppositories
ATC code C05AA C05AA
ATC description AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2013-03-01 2013-03-01
Estimated end date Unknown Unknown
Actual end date 2017-04-05 2017-04-05
Shortage status Resolved Resolved
Company comments
Health Canada comments